AlensiaXR — SEC Form D Filing

AlensiaXR filed an SEC Form D on January 8, 2026, reporting $2.12M raised in EdTech.

Form D filing details

Filing
SEC Form D
Filing date
January 8, 2026
Amount reported
$2.12M
Round stage
Seed
Industry
EdTech
Headquarters
Cleveland, OH, USA
Website
https://www.alensiaxr.com/

What the company does

Securities: Equity. Exemption: Rule 506(b). Incorporated: DELAWARE

Problem

Traditional methods for teaching anatomy, neuroanatomy, and health sciences are often expensive, time-consuming, and can lead to lower retention rates for complex concepts.

Solution

AlensiaXR provides immersive 3D anatomy software using extended reality (XR) technology, enabling healthcare students to learn complex anatomical structures faster, retain information longer, and engage more deeply with the material.

Verdict

This cleared because it presented a clear cost-saving and efficiency play, not because it promised novel educational outcomes. Investors were implicitly betting on predictable B2B university procurement cycles and the immediate, albeit niche, utility of XR over traditional methods. The upside was limited by the relatively small addressable market within higher education and the risk of being a feature, not a platform, for broader educational transformation.

Source: SEC EDGAR Form D filing